Larson Financial Group’s Arcadia Biosciences RKDA Stock Holding History

Larson Financial Group’s Portfolio RKDA Stock Details RKDA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-1	Closed	-$3	–	3468
2025 Q1	$3	Buy	+1	New	+$4	﹤0.01%	3063

Other funds holding RKDA

Mariner Overland Park, Kansas $85.7B AUM 24.21% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

AWM

Atticus Wealth Management Palm Beach Gardens, Florida $420M AUM 23.31% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Larson Financial Group's RKDA Position: Q2 2025 in Review

Larson Financial Group sold out of Arcadia Biosciences (RKDA) in Q2 2025, closing a stake of 1 share — an estimated $3 sold.

Larson Financial Group first reported a position in RKDA in Q1 2025 and held it in 1 quarter. The position peaked at $3 in Q1 2025. 14 funds tracked by Wall St. Rank hold RKDA as of Q2 2025.

Larson Financial Group reported no remaining Arcadia Biosciences position as of Q2 2025 after selling out during the quarter.
Larson Financial Group sold 1 Arcadia Biosciences share in Q2 2025, an estimated $3.
Larson Financial Group first reported a position in Arcadia Biosciences in Q1 2025 and held it in 1 quarter.
Larson Financial Group's Arcadia Biosciences position peaked at $3 in Q1 2025.
14 funds tracked by Wall St. Rank held Arcadia Biosciences as of Q2 2025.

Based on Larson Financial Group's 13F filing for Q2 2025, filed 8 Aug 2025.